Get the latest Science News and Discoveries
Scientists May Now Know Why GLP-1s Don't Work For 10% of People
Certain genetic variants, carried by around 10 percent of the population, could be making type 2 diabetes GLP-1 treatments (such as Ozempic and Wegovy) less effective, according to new research.
None
Or read this on Science Alert
